Clinical Manufacturing Site Approved for Molecular Profiles - - BioPharm International

ADVERTISEMENT

Clinical Manufacturing Site Approved for Molecular Profiles


UK-based contract research and manufacturing organization Molecular Profiles has opened its new facility following a successful inspection from the Medicines and Healthcare products Regulatory Agency (MHRA). The Nottingham-based, pharmaceutical production site will provide clinical manufacturing capabilities.

This new facility marks a significant expansion for the company that started life as a spin-out from Nottingham University more than 15 years ago, the company reports. The investment adds six GMP suites, new laboratories, and a clinical packing area to support clients’ Phase I and II clinical trial projects.

The approval of the company’s cGMP-compliant facility follows a recent visit from Nick Clegg, Deputy Prime Minister of the UK Government, which provided £1.6m to the expansion through the regional growth fund grant. The new manufacturing site supports Molecular Profiles’ alliance with Onyx Scientific, which delivers pharmaceutical development services from drug discovery through the later phases of clinical development.

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines

Click here